Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2020-08-05 Earnings Release
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
FORM 8-K 13 pages 92.8KB
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 5, 2020, by ResMed Inc. It includes a press release announcing the company's quarterly and full fiscal year 2020 financial results, with detailed financial data such as revenue, gross margin, net income, and earnings per share. The document also contains operational highlights, dividend declaration details, and information about a webcast for discussing the earnings results. The presence of detailed quarterly and annual financial results and operational commentary indicates this is an Earnings Release. The document is not a full annual report (10-K) or interim report (IR) but a current report focusing on quarterly earnings results. Therefore, the appropriate classification is Earnings Release (ER). The document length and content support a high confidence score. FY 2020
2020-08-05 English
Chess Depositary Interest - RMD 3 pages 22.2KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Statement of CDIs on Issue' and details the number and class of CHESS Depositary Interests (CDIs) and other securities on issue for ResMed Inc. It includes monthly figures for July 2020, net differences from previous months, and reasons for changes such as transfers and new shares issued under employee plans. There is no financial performance data, management discussion, or regulatory certification. The document is a detailed statement about securities on issue, which aligns with announcements about share capital or securities issued. It is not a full financial report, earnings release, or management report. Given the focus on securities issued and changes in share capital, the most appropriate classification is Share Issue/Capital Change (SHA). The document length is under 5,000 characters, but it contains substantive data about securities issued, not just an announcement of a report, so it is not RPA or RNS.
2020-08-04 English
RMD to Report Fourth Quarter Fiscal 2020 Results 1
Regulatory Filings Classification · 95% confidence The document is a short announcement from ResMed about the upcoming release of their fourth quarter fiscal 2020 earnings on August 5, 2020. It includes details about the earnings webcast and replay information but does not contain any actual financial results or detailed financial data. The document length is only 2132 characters, which is quite short and consistent with an earnings release announcement rather than the earnings release itself. According to the rules, announcements about upcoming earnings releases or calls without actual financial data should be classified as Earnings Release (ER) if they contain key highlights or initial financial results, but this document only announces the date and webcast details without financial highlights. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the earnings release timing and webcast, not the earnings release itself.
2020-07-15 English
Chess Depositary Interest - RMD 3 pages 22.4KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Statement of CDIs on Issue' and provides detailed information about the number and class of CHESS Depositary Interests (CDIs) and other securities on issue for ResMed Inc. It includes monthly data for June 2020, net differences in securities, and reasons for changes such as transfers and new shares issued under employee plans. The content focuses on securities issued and changes in share capital representation rather than financial results, management changes, or regulatory announcements. The document length is 2780 characters, which is relatively short but contains substantive data about securities on issue. This fits the description of a Share Issue/Capital Change announcement, which covers new share issues, stock splits, or other capital changes. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2020-07-05 English
Chess Depositary Interest - RMD 3 pages 22.3KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Statement of CDIs on Issue' and provides detailed information about the number and class of CHESS Depositary Interests (CDIs) and other securities on issue for ResMed Inc. It includes monthly data for May 2020, changes in securities, and reasons for those changes such as transfers and new shares issued under employee plans. The document is a formal announcement of the securities outstanding and changes in share capital representation but does not contain financial statements, management discussion, or other report content. It is not a full financial report, earnings release, or management report. The content aligns with announcements related to share capital changes or share issuance. Given the focus on securities issued and changes in CDIs, the most appropriate classification is Share Issue/Capital Change (SHA). The document length is 2781 characters, which is relatively short and consistent with an announcement rather than a full report.
2020-06-03 English
ResMed FORM SD 7 pages 52.5KB
Regulatory Filings Classification · 100% confidence The document is a Form SD filed with the SEC, specifically a Specialized Disclosure Report related to conflict minerals for the reporting period January 1 to December 31, 2019. It includes detailed disclosure about the company's due diligence process on conflict minerals, supply chain information, and compliance with Exchange Act Rule 13p-1. The document is not an annual report, earnings release, or any other financial report but a specialized regulatory filing focused on conflict minerals disclosure. Form SD filings are specialized regulatory filings required by the SEC and do not fall under other categories like Annual Report (10-K) or Interim Report (IR). Therefore, the appropriate classification is Regulatory Filings (RNS). The document length (15,000 characters) and content confirm it is the report itself, not just an announcement or certification, but it is still a regulatory filing type.
2020-05-24 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.